Review decisions
Showing 790 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00928
Product Type: Drug
Control Number: 258658
Manufacturer: ModernaTX, Inc.
Submission Type: Supplement to a New Drug Submission (COVID-19)
Date Filed / Submission Date: 2021-11-16
Decision / Authorization Date: 2022-03-17
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00932
Product Type: Drug
Control Number: 251455
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-04-08
Decision / Authorization Date: 2022-03-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01091
Product Type: Drug
Control Number: 233561
DIN(s): 02525968, 02526018, 02526026, 02526034
Manufacturer: Heron Therapeutics, Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2019-11-18
Decision / Authorization Date: 2022-03-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1755873445495
Product Type: Drug
Control Number: 259183
DIN(s): 02535858, 02558238
Manufacturer: Biosimilar Collaborations Ireland Limited
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-03-16
Issued / Original Publication Date: 2025-08-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00930
Product Type: Drug
Control Number: 251162
Manufacturer: Samsung Bioepis Co., Ltd.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-03-29
Decision / Authorization Date: 2022-03-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00927
Product Type: Drug
Control Number: 251147
Manufacturer: Seqirus UK Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-03-31
Decision / Authorization Date: 2022-03-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1684955300002
Product Type: Drug
Control Number: 262122
DIN(s): 02535270
Manufacturer: Janssen Inc.
Submission Type: New Drug Submission (New Active Substance) - Notice of Compliance with Conditions
Date Filed / Submission Date: 2022-03-04
Issued / Original Publication Date: 2023-05-09
Decision / Authorization Date: 2023-02-09
Updated Date: 2025-05-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00926
Product Type: Drug
Control Number: 255450
Manufacturer: Bristol-Myers Squibb Canada Co.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-08-04
Decision / Authorization Date: 2022-03-03
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1732290566153
Product Type: Drug
Control Number: 261973
Manufacturer: Orimed Pharma Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-03-02
Decision / Authorization Date: 2024-03-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00923
Product Type: Drug
Control Number: 250272
DIN(s): 02525569
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-03-10
Decision / Authorization Date: 2022-03-01